FDA孤儿药称号-话题@MedSci

#FDA孤儿药称号#

9篇内容 | 891人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1379839, encodeId=7e4913e983919, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, objectTitle=梦想照进现实！二代NTRK抑制剂获FDA孤儿药称号, objectType=article, longId=731988, objectId=774ce3198835, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=774ce3198835, replyNumber=0, likeNumber=53, createdTime=2022-07-12, rootId=0, userName=mxj1971612, userId=8ebe466, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=774ce3198835, moduleTitle=梦想照进现实！二代NTRK抑制剂获FDA孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=774ce3198835)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379838, encodeId=4ed113e9838c4, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, objectTitle=大麻二酚（Cannabidiol）治疗22q11.2缺失综合症：已获FDA孤儿药称号, objectType=article, longId=200908, objectId=e5d6200908d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5d6200908d5, replyNumber=0, likeNumber=52, createdTime=2020-09-20, rootId=0, userName=mxj1971612, userId=8ebe466, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5d6200908d5, moduleTitle=大麻二酚（Cannabidiol）治疗22q11.2缺失综合症：已获FDA孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5d6200908d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379837, encodeId=a32513e98373b, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, objectTitle=泛发性脓疱型银屑病：Imsidolimab获FDA孤儿药称号, objectType=article, longId=197298, objectId=6b4219e29846, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b4219e29846, replyNumber=0, likeNumber=52, createdTime=2020-07-11, rootId=0, userName=mxj1971612, userId=8ebe466, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b4219e29846, moduleTitle=泛发性脓疱型银屑病：Imsidolimab获FDA孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b4219e29846)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379836, encodeId=db2213e983675, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, objectTitle=EB病毒相关肿瘤的治疗：nanatinostat和valganciclovir联合方案获FDA孤儿药称号, objectType=article, longId=196509, objectId=412c196509e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=412c196509e8, replyNumber=0, likeNumber=39, createdTime=2020-06-27, rootId=0, userName=mxj1971612, userId=8ebe466, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=412c196509e8, moduleTitle=EB病毒相关肿瘤的治疗：nanatinostat和valganciclovir联合方案获FDA孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=412c196509e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379835, encodeId=55db13e9835d4, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, objectTitle=原发性线粒体肌病的治疗：REN001获得FDA孤儿药称号, objectType=article, longId=196428, objectId=64ef1964289f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64ef1964289f, replyNumber=0, likeNumber=37, createdTime=2020-06-26, rootId=0, userName=mxj1971612, userId=8ebe466, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64ef1964289f, moduleTitle=原发性线粒体肌病的治疗：REN001获得FDA孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64ef1964289f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379834, encodeId=c68213e983456, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, objectTitle=坏死性小肠结肠炎（NEC）的治疗：人胎盘提取物Protego-PD™获得FDA孤儿药称号, objectType=article, longId=196209, objectId=f2bb19620971, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2bb19620971, replyNumber=0, likeNumber=56, createdTime=2020-06-22, rootId=0, userName=mxj1971612, userId=8ebe466, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2bb19620971, moduleTitle=坏死性小肠结肠炎（NEC）的治疗：人胎盘提取物Protego-PD™获得FDA孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2bb19620971)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379833, encodeId=535f13e98337e, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, objectTitle=Hanmi的NASH候选药物HM15211治疗硬化性胆管炎，获得FDA孤儿药称号, objectType=article, longId=189674, objectId=42571896e458, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42571896e458, replyNumber=0, likeNumber=50, createdTime=2020-03-12, rootId=0, userName=mxj1971612, userId=8ebe466, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42571896e458, moduleTitle=Hanmi的NASH候选药物HM15211治疗硬化性胆管炎，获得FDA孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42571896e458)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379832, encodeId=79e713e983223, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, objectTitle=复星医药新开发的白血病药物FN-1501获得FDA孤儿药称号, objectType=article, longId=183900, objectId=823f18390056, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=823f18390056, replyNumber=0, likeNumber=46, createdTime=2019-12-02, rootId=0, userName=mxj1971612, userId=8ebe466, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=823f18390056, moduleTitle=复星医药新开发的白血病药物FN-1501获得FDA孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=823f18390056)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1379831, encodeId=ce0813e983191, content=<a href='/topic/show?id=72fee303d6' target=_blank style='color:#2F92EE;'>#FDA孤儿药称号#</a>, objectTitle=Minoryx公司的PPRP激动剂来瑞格列酮治疗Friedreich共济失调，获得FDA孤儿药称号, objectType=article, longId=181655, objectId=22581816559a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22581816559a, replyNumber=0, likeNumber=54, createdTime=2019-10-22, rootId=0, userName=mxj1971612, userId=8ebe466, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22581816559a, moduleTitle=Minoryx公司的PPRP激动剂来瑞格列酮治疗Friedreich共济失调，获得FDA孤儿药称号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22581816559a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

FDA孤儿药称号

2020-05-29

mxj1971612 (审核中...)

前往app查看评论内容

#FDA孤儿药称号#

梦想照进现实！二代NTRK抑制剂获FDA孤儿药称号

2022-07-12

mxj1971612 (审核中...)

前往app查看评论内容

#FDA孤儿药称号#

大麻二酚（Cannabidiol）治疗22q11.2缺失综合症：已获FDA孤儿药称号

2020-09-20

mxj1971612 (审核中...)

前往app查看评论内容

#FDA孤儿药称号#

泛发性脓疱型银屑病：Imsidolimab获FDA孤儿药称号

2020-07-11

mxj1971612 (审核中...)

前往app查看评论内容

#FDA孤儿药称号#

EB病毒相关肿瘤的治疗：nanatinostat和valganciclovir联合方案获FDA孤儿药称号

2020-06-27

mxj1971612 (审核中...)

前往app查看评论内容

#FDA孤儿药称号#

原发性线粒体肌病的治疗：REN001获得FDA孤儿药称号

2020-06-26

mxj1971612 (审核中...)

前往app查看评论内容

#FDA孤儿药称号#

坏死性小肠结肠炎（NEC）的治疗：人胎盘提取物Protego-PD™获得FDA孤儿药称号

2020-06-22

mxj1971612 (审核中...)

前往app查看评论内容

#FDA孤儿药称号#

Hanmi的NASH候选药物HM15211治疗硬化性胆管炎，获得FDA孤儿药称号

2020-03-12

mxj1971612 (审核中...)

前往app查看评论内容

#FDA孤儿药称号#

复星医药新开发的白血病药物FN-1501获得FDA孤儿药称号

2019-12-02

mxj1971612 (审核中...)

前往app查看评论内容

#FDA孤儿药称号#

Minoryx公司的PPRP激动剂来瑞格列酮治疗Friedreich共济失调，获得FDA孤儿药称号

2019-10-22

科室
- - 订阅+
  - 更多科室
工具
服务